Strides Shasun's wholly owned subsidiary Strides Pharma Global Pte. Limited has received approval for Nystatin and Triamcinolone Acetonide Ointment USP, 0.1% from the United States Food & Drug Administration (USFDA).
This is the first topical approval received from the new semi solids block at the flagship plant in Bangalore. Source : BSE
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
